Overall, these in vivo and clinical experiments provide compelling evidence supporting the role of the NSUN5/WDR5‐SMAD3‐EMT axis in promoting the malignant progression of HCC, underscoring its significant clinical implications. This evidence concerns the gene NSUN5 and hepatocellular carcinoma.